EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer. Cancer. 2009 Jun 15; 115(12):2684-92.